Astrazeneca Receives First European Approval For Nexium R In Pediatric Gerd

AstraZeneca announced that it has received Swedish Medical Products Agency (MPA) approval for use of Nexium(R) (esomeprazole) in children aged 1-11 years with gastroesophageal reflux disease (GERD) in the reference member state of Sweden, with other European Union nations expected to follow. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: